CoChat

Investigation of the KIR4.1 potassium channel as a putative antigen in patients with multiple sclerosis: a comparative study

Open access
Brickshawana, Adipong, Hinson, Shannon R, Romero, Michael F, Lucchinetti, Claudia F, Guo, Yong, Buttmann, Mathias, McKeon, Andrew, Pittock, Sean J, Chang, Min-Hwang, Chen, An-Ping, Kryzer, Thomas J, Fryer, James P, Jenkins, Sarah M, Cabre, Philippe, Lennon, Vanda A · 2014 · The Lancet Neurology
Cited by 83

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Abstract

Summary Background Antibody-dependent pathogenicity is suggested in multiple sclerosis (MS) by intrathecal immunoglobulin production, IgG and complement deposition in the most common immunopathological lesion subtype (pattern II), and by a recent report that 47% of MS patients’ sera contain a glial potassium-channel-specific-IgG(inwardly-rectifying, Kir4.1). Our study’s aims were to determine, in MS serum and CSF, the frequency and specificity of Kir4.1-binding-IgG and, in demyelinating MS lesions, whether Kir4.1-immunoreactivity is retained or lost. Methods We tested by ELISA(Kir4.1-peptide 83–120) sera from 286 clinically and geographically diverse MS patients (229 population-based and 57 clinic-based),99 healthy controls and 109 disease controls, and cerebrospinal fluid [CSF] from 25 MS and 22 controls. CSFs and clinic-based MS-subset serum (50)were tested on functional Kir4.1-expressing cells, using methodologies validated for detecting clinically-pertinent neural plasma membrane-reactive autoantibodies: immunofluorescence and immunoprecipitation (solubilized recombinant human Kir4.1). We evaluated Kir4.1-immunoreactivity in brain from 15 archival histopathologically-confirmed MS cases(22 plaques: 8 early active, 8 inactive, 6 remyelinated; 13 periplaque regions)and compared 3 non-neurological cases (8 normal-appearing white/gray matter regions). Findings Kir4.1-peptide-ELISA reactivity was rare and did not differ significantly for 286 MS or 208 control sera (both 1%); no CSF was positive. IgGin 0/50 clinic-based MS sera immunoprecipitated Kir4.1, but control Kir4.1-specific-IgG did. By immunofluorescence,1/50 MS sera yielded faint plasmalemmal staining on both Kir4.1-expressing and non-expressing cells; 16/50 bound faintly to intracellular components. In all cases, IgG binding was quenched by absorption with liver powder or non-transfected cell lysates. Control Kir4.1-specific-IgG binding was quenched only by Kir4.1 protein-containing lysates. IgG in 0/25 MS CSFs bound to Kir4.1-transfected cells, live or fixed. Glial Kir4.1-immunoreactivity was increased relative to baseline normal brain expression (3 controls) in early active and remyelinated MS lesions, and in periplaque white matter (15 patients). Interpretation We did not find Kir4.1-specific-IgG in MS sera or CSF, nor Kir4.1 loss from glial cells in active demyelinating MS lesions. Serological testing for Kir4.1-IgG is unlikely to aid MS diagnosis. The target antigen of MS remains elusive. Funding The National Institutes of Health, the National Multiple Sclerosis Society and the Mayo Clinic Robert and Arlene Kogod Center on Aging.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/s1474-4422(14)70141-3

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 5 references

Cited by

See all 83

Metadata

Authors
Brickshawana, A., Hinson, S. R., Romero, M. F., Lucchinetti, C. F., Guo, Y., Buttmann, M., McKeon, A., Pittock, S. J., Chang, M.-H., Chen, A.-P., Kryzer, T. J., Fryer, J. P., Jenkins, S. M., Cabre, P., & Lennon, V. A.
Venue
The Lancet Neurology
Publisher
Elsevier BV
Published
2014-08
Volume
13
Issue
8
Pages
795-806
ISSN
1474-4422 (ISSN-L)
OpenAlex
W1993868490
Cited by
83
References
5
FWCI
11.78
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Investigation of the KIR4.1 potassium channel as a putative antigen in patients with multiple sclerosis: a comparative study. https://app.cochat.ai/papers/10.1016/s1474-4422(14)70141-3
The paper
Brickshawana, A., Hinson, S. R., Romero, M. F., Lucchinetti, C. F., Guo, Y., Buttmann, M., McKeon, A., Pittock, S. J., Chang, M.-H., Chen, A.-P., Kryzer, T. J., Fryer, J. P., Jenkins, S. M., Cabre, P., & Lennon, V. A. (2014). Investigation of the KIR4.1 potassium channel as a putative antigen in patients with multiple sclerosis: a comparative study. The Lancet Neurology. https://doi.org/10.1016/s1474-4422(14)70141-3

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.